A Houston compounding pharmacy has recalled three injectable wellness products nationwide after nine people reported getting sick following shots meant to boost energy and immunity. Centric Compounding LLC pulled its Glutathione 200 mg/mL, Myer’s Cocktail and Tri-Immune Boost multidose vials on Sept. 9, 2026, after testing linked the products to elevated endotoxin levels. The FDA published the recall notice on Sept. 13. The nine people affected reported fever, chills, chest pain, nausea, vomiting, headache and malaise after receiving the injections.
The vials were sold nationwide through home delivery and directly to prescribers, not over a pharmacy counter, which is how a contamination problem traced to one Houston facility reached patients across the country before anyone connected the reactions to a single source.
What Went Wrong Inside the Vials
The problem traces to the raw glutathione ingredient itself. Centric Compounding said its Glutathione 200 mg/mL, Myer’s Cocktail and Tri-Immune Boost vials were compounded with a glutathione active ingredient containing elevated endotoxin levels. Endotoxins are fragments of bacterial cell walls that survive even after the bacteria themselves are killed, and injecting them directly into the bloodstream bypasses the body’s usual defenses against them.
The recall notice did not soften what that can mean. “Injectable products with elevated endotoxin levels could cause significant medical events including fevers, hypotension, inflammatory reactions, anaphylactic shock and death,” it read. The affected lots carry beyond-use dates spanning Aug. 7 through Sept. 25, 2026, meaning some vials would not have expired on their own for weeks after the recall was announced.
Nine Reports, and What They Have in Common
All nine adverse-event reports describe a similar pattern: fever, chills, chest pain, nausea or vomiting, headache and malaise surfacing after an injection. Those are textbook symptoms of an endotoxin reaction rather than a routine side effect, which is part of why the recall covers not just the Glutathione vials but the two other products, Myer’s Cocktail and Tri-Immune Boost, that were compounded using the same suspect ingredient lot.
Centric Compounding is telling patients and providers to stop using any of the affected vials immediately and discard them, and to contact a physician if symptoms consistent with the nine reported cases develop after an injection. Anyone with questions about the recall can reach the company directly at 833-777-6664 or [email protected], weekdays from 9 a.m. to 5 p.m. Central time.
All three products came in 30 mL multidose vials, meaning a single contaminated container was designed to be drawn from repeatedly across several patient visits before it was empty. That format is part of why nine separate reactions surfaced before the source was traced back to one supplier: patients receiving the shots at different clinics, on different days, had no obvious reason to connect their symptoms to each other.
Compounding pharmacies like Centric Compounding operate under a different regulatory track than drug manufacturers. They are permitted to mix injectable products for individual patients or in office-use quantities without going through the FDA’s standard new-drug approval process, and day-to-day oversight falls mainly to state pharmacy boards, with the FDA stepping in once a quality problem, like elevated endotoxin levels, surfaces.
The Third Endotoxin Recall From a Texas Compounder in Weeks
Centric Compounding’s recall was not an isolated event. It was the third Texas compounding pharmacy in a matter of weeks to pull glutathione injectables over the same underlying problem. Victory Medical Center Pharmacy in Austin recalled its own 200 mg/mL glutathione injectable on Aug. 5, and Optimal Balance Pharmacy, also in Houston, followed on Aug. 19 with a nationwide recall of its own contaminated glutathione lots.
By the time patient reactions to the Optimal Balance lot were logged, product had already reached 14 states. Three separate compounders producing the same type of contaminated ingredient inside a single month points to a supply-chain problem upstream of any one pharmacy, rather than a one-off manufacturing lapse at Centric Compounding alone.
A Known Risk the FDA Flagged Years Earlier
None of this is new territory for regulators. In a 2019 safety communication, the FDA warned that dietary-grade glutathione is unsuited for sterile injectables, after its own testing found L-glutathione samples containing bacterial endotoxin levels up to five times the appropriate limit. Seven patients were sickened in the cases that prompted that warning, all after receiving injections made from glutathione labeled explicitly as “not for pharmaceutical use.”
The agency’s broader guidance on the subject explains why the ingredient itself, not just the compounding process, matters so much: its technical guide on bacterial endotoxins and pyrogens notes that standard sterilization can kill bacteria without destroying the endotoxin residue left behind, meaning a compounder can pass a sterility test while still shipping a contaminated vial.
Seven years after that first warning, the pattern is repeating at three different Texas facilities in the same month, with the nine cases tied to Centric Compounding the latest tally in a problem regulators have been documenting since at least 2019.
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
More from Morning Overview
- Amazon’s Prime refunds are rising to $200 as millions more customers become eligible
- A handful of car engines are so tough mechanics say they almost never wear out
- The NSA is again telling phone owners to switch off one location setting
- Supplements now rank as the fifth-leading cause of death from liver disease.
